Application of PCSK9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia
Clinical trial NCT04759534 · UNKNOWN
Trial details
- NCT number
- NCT04759534
- Sponsor
- Shenzhen People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2021-10-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.